Edward S. Morris

1.3k citations

25 papers · 958 indexed · h-index 15

Co-authors: Geoffrey R. Hill Kelli P. A. MacDonald Vanessa Rowe Tatjana Banovic Andrew D. Clouston Rachel D. Kuns Alistair Don Angela Burman
Topics: Hematopoietic Stem Cell Transplantation (12 papers)Immune Cell Function and Interaction (12 papers)T-cell and B-cell Immunology (11 papers)
Cited by: Hematology Immunology Oncology
Journals: Journal of Clinical Investigation Nature Medicine Blood
Partner nations: Australia United Kingdom New Zealand

In The Last Decade

Edward S. Morris

23 papers receiving 949 citations

Peers

Countries citing papers authored by Edward S. Morris

Since Specialization

Citations

This map shows the geographic impact of Edward S. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward S. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward S. Morris more than expected).

Fields of papers citing papers by Edward S. Morris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward S. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward S. Morris. The network helps show where Edward S. Morris may publish in the future.

Co-authorship network of co-authors of Edward S. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Edward S. Morris. A scholar is included among the top collaborators of Edward S. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward S. Morris. Edward S. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ANZTCT practice statement: sinusoidal obstruction syndrome/veno‐occlusive disease diagnosis and management 2024 ·Internal Medicine Journal ·Shaun Fleming,(unknown),John Coutsouvelis,Chris Fraser,Ashish Bajel,(unknown),Rachel Conyers,Ashley McEwan,David T Yeung,(unknown),Lochie Teague,(unknown),Edward S. Morris,Melissa Gabriel,(unknown),(unknown),(unknown),Nada Hamad	0
2	High Deliverability of a Midostaurin Triplet Regimen Incorporating Venetoclax and Low Dose Cytarabine in Non-Adverse Cytogenetic Risk Acute Myeloid Leukaemia: A Sub-Analysis of the Australasian Leukaemia Lymphoma Group (ALLG) Intervene Study 2022 ·Blood ·Chong Chyn Chua,Natasha S. Anstee,Anoop Enjeti,Devendra Hiwase,Paula Marlton,Ashish Bajel,(unknown),Edward S. Morris,(unknown),Carolyn Grove,Julian Cooney,(unknown),Rachel Koldej,Stephen B. Ting,Travis Perera,Amanda Johnston,John Reynolds,David Ritchie,Andrew H. Wei	5
3	An Australasian Leukemia Lymphoma Group (ALLG) Phase 2 Study to Investigate Novel Triplets to Extend Remission with Venetoclax in Elderly (INTERVENE) Acute Myeloid Leukemia 2021 ·Blood ·Chong Chyn Chua,John Reynolds,Anoop Enjeti,Devendra Hiwase,Paula Marlton,Ashish Bajel,(unknown),Edward S. Morris,(unknown),Carolyn Grove,Julian Cooney,(unknown),Natasha S. Anstee,Stephen B. Ting,Travis Perera,Amanda Johnston,David Ritchie,Andrew H. Wei	2
4	A 14‐year retrospective analysis of indications and outcomes of autologous haemopoietic stem cell transplantation in regional Queensland: a single‐centre experience 2019 ·Internal Medicine Journal ·Elizabeth Hamilton,Karthik Nath,Venkat Vangaveti,(unknown),(unknown),(unknown),John Casey,Caroline McNamara,(unknown),Edward S. Morris,(unknown),(unknown)	2
5	A retrospective analysis of the prevalence and clinical outcomes of vitamin D deficiency in myeloma patients in tropical Australia 2019 ·Supportive Care in Cancer ·Karthik Nath,(unknown),(unknown),(unknown),Kerrianne Watt,(unknown),John Casey,(unknown),Edward S. Morris,(unknown)	13
6	Screening whole spine magnetic resonance imaging in multiple myeloma 2015 ·Internal Medicine Journal ·Joel Wight,(unknown),Edward S. Morris,(unknown),(unknown),(unknown)	1
7	Induction of natural killer T cell–dependent alloreactivity by administration of granulocyte colony–stimulating factor after bone marrow transplantation 2009 ·Nature Medicine ·Edward S. Morris,Kelli P. A. MacDonald,Rachel D. Kuns,(unknown),Tatjana Banovic,Alistair Don,Vanessa Rowe,Yana A. Wilson,Neil C. Raffelt,Christian Engwerda,Angela Burman,Kate A. Markey,Dale I. Godfrey,Mark J. Smyth,Geoffrey R. Hill	48
8	Invariant natural killer T cell–natural killer cell interactions dictate transplantation outcome after α-galactosylceramide administration 2009 ·Blood ·Rachel D. Kuns,Edward S. Morris,Kelli P. A. MacDonald,Kate A. Markey,(unknown),Neil C. Raffelt,Tatjana Banovic,Alistair Don,Vanessa Rowe,Angela Burman,Andrew D. Clouston,Camile S. Farah,Gurdyal S. Besra,Petr A. Illarionov,Mark J. Smyth,Steven A. Porcelli,Geoffrey R. Hill	21
9	Donor Treatment with a Multipegylated G-CSF Maximizes Graft-versus-Leukemia Effects 2009 ·Biology of Blood and Marrow Transplantation ·Tatjana Banovic,Kelli P. A. MacDonald,Kate A. Markey,Edward S. Morris,Rachel D. Kuns,Antiopi Varelias,Geoffrey R. Hill	5
10	Advances in the understanding of acute graft‐versus‐host disease 2007 ·British Journal of Haematology ·Edward S. Morris,Geoffrey R. Hill	40
11	IFNγ differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract 2007 ·Blood ·Angela Burman,Tatjana Banovic,Rachel D. Kuns,Andrew D. Clouston,Amanda C. Stanley,Edward S. Morris,Vanessa Rowe,(unknown),Renae Skoczylas,Neil C. Raffelt,Olivier Fahy,Shaun R. McColl,Christian Engwerda,(unknown),Geoffrey R. Hill	136
12	Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation 2006 ·Blood ·Vanessa Rowe,Tatjana Banovic,Kelli P. A. MacDonald,Rachel D. Kuns,Alistair Don,Edward S. Morris,Angela Burman,(unknown),Andrew D. Clouston,Geoffrey R. Hill	99
13	Allogeneic Stem Cell Transplantation with Peripheral Blood Stem Cells Mobilized by Pegylated G-CSF 2006 ·Biology of Blood and Marrow Transplantation ·Geoffrey R. Hill,Edward S. Morris,(unknown),Cheryl Hutchins,Jason Butler,Andrew Grigg,Andrew W. Roberts,Ken Bradstock,Jeff Szer,Glen Kennedy,James Morton,Simon Durrant	30
14	Tumor-Derived Interleukin-4 Reduces Tumor Clearance and Deviates the Cytokine and Granzyme Profile of Tumor-Induced CD8+ T Cells 2006 ·Cancer Research ·Stuart D. Olver,Penny Groves,Kathy Buttigieg,Edward S. Morris,Michelle L. Janas,Anne Kelso,Norbert Kienzle	37
15	Nuclear Translocation of RelB within Host and Donor Antigen Presenting Cells Is Critical for the Initiation and Maintenance of Acute Graft-Versus-Host Disease. 2005 ·Blood ·Kelli P. A. MacDonald,Rachel D. Kuns,Vanessa Rowe,Alistair Don,Edward S. Morris,Ranjeny Thomas,Geoffrey R. Hill	1
16	NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs 2005 ·Journal of Clinical Investigation ·Edward S. Morris	99
17	TGF-β in allogeneic stem cell transplantation: friend or foe? 2005 ·Blood ·Tatjana Banovic,Kelli P. A. MacDonald,Edward S. Morris,Vanessa Rowe,Rachel D. Kuns,Alistair Don,(unknown),Steve Ledbetter,Andrew D. Clouston,Geoffrey R. Hill	109
18	Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation 2004 ·Biology of Blood and Marrow Transplantation ·Kelli P. A. MacDonald,Vanessa Rowe,Cheryl Filippich,Diana Johnson,Edward S. Morris,Andrew D. Clouston,James L.M. Ferrara,Geoffrey R. Hill	19
19	Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance 2004 ·Blood ·Edward S. Morris,Kelli P. A. MacDonald,Vanessa Rowe,Diana Johnson,Tatjana Banovic,Andrew D. Clouston,Geoffrey R. Hill	108
20	The management of von Willebrand's disease-associated gastrointestinal angiodysplasia 2001 ·Blood Coagulation & Fibrinolysis ·Edward S. Morris,K. K. Hampton,I. M. Nesbitt,F E Preston,(unknown),Μichael Μakris	24

About Edward S. Morris

Edward S. Morris is a scholar working on Hematology, Immunology and Genetics, having authored 25 papers that have together received 958 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (12 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (11 papers). The work is most often cited by research in Hematology (623 citations), Immunology (691 citations) and Oncology (190 citations). Edward S. Morris has collaborated with scholars based in Australia, United Kingdom and New Zealand. Frequent co-authors include Geoffrey R. Hill, Kelli P. A. MacDonald, Vanessa Rowe, Tatjana Banovic, Andrew D. Clouston, Rachel D. Kuns, Alistair Don, Angela Burman, Diana Johnson and Neil C. Raffelt. Their work appears in journals such as Journal of Clinical Investigation, Nature Medicine and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact